DRTS vs. QIPT, ARAY, CVRX, OBIO, CLPT, DCTH, PROF, TELA, KRMD, and BWAY
Should you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include Quipt Home Medical (QIPT), Accuray (ARAY), CVRx (CVRX), Orchestra BioMed (OBIO), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Profound Medical (PROF), TELA Bio (TELA), KORU Medical Systems (KRMD), and BrainsWay (BWAY). These companies are all part of the "surgical & medical instruments" industry.
Quipt Home Medical (NASDAQ:QIPT) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.
Quipt Home Medical has higher revenue and earnings than Alpha Tau Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.
Quipt Home Medical received 14 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 81.25% of users gave Quipt Home Medical an outperform vote while only 60.00% of users gave Alpha Tau Medical an outperform vote.
In the previous week, Quipt Home Medical had 11 more articles in the media than Alpha Tau Medical. MarketBeat recorded 15 mentions for Quipt Home Medical and 4 mentions for Alpha Tau Medical. Quipt Home Medical's average media sentiment score of 0.15 beat Alpha Tau Medical's score of -0.68 indicating that Alpha Tau Medical is being referred to more favorably in the news media.
42.9% of Quipt Home Medical shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 4.2% of Quipt Home Medical shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Alpha Tau Medical has a net margin of 0.00% compared to Alpha Tau Medical's net margin of -1.71%. Alpha Tau Medical's return on equity of -3.89% beat Quipt Home Medical's return on equity.
Quipt Home Medical presently has a consensus price target of $7.50, suggesting a potential upside of 138.10%. Alpha Tau Medical has a consensus price target of $12.00, suggesting a potential upside of 324.03%. Given Quipt Home Medical's stronger consensus rating and higher possible upside, analysts clearly believe Alpha Tau Medical is more favorable than Quipt Home Medical.
Quipt Home Medical has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500.
Summary
Quipt Home Medical beats Alpha Tau Medical on 9 of the 17 factors compared between the two stocks.
Get Alpha Tau Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alpha Tau Medical Competitors List
Related Companies and Tools
